Glenn Short
InvestorChief Scientific Officer at atai Life Sciences
Boston, Massachusetts, United States
About
Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.
Experience
- Viridia Life SciencesBoard Member2022 — 2023
- Viridia Life SciencesChief Executive Officer2020 — 2022
- EmpathBioBoard Member2022 — 2023
- EmpathBioChief Executive Officer2020 — 2022
- EntheogeniX BiosciencesChief Executive Officer2022 — 2023
- EntheogeniX BiosciencesChief Scientific Officer2019 — 2022
- Glenn Short ConsultingSenior Biotech and Pharmaceutical R&D Consultant2019
- Axial Biotherapeutics, Inc.VP, Early Development2019
- Flex PharmaVP level, Pharmaceutical R&D Consultant2018 — 2019
- Flex PharmaVP, Research and Translational Development2017 — 2018
- Flex PharmaVP, Nonclinical and Translational Research2017
- Flex PharmaSenior Director, Research2014 — 2017
- BiotechnologyBiotechnology Consultant2014
- Zalicus IncorporatedSenior Director, Research2012 — 2013cambridge, ma
- Zalicus IncorporatedDirector of Discovery Sciences2009 — 2012Cambridge, MA
- CombinatoRx, Inc.Team Leader in Discovery Biology2007 — 2009Cambridge, MA
- CombinatoRx, Inc.Senior Scientist in Platform/Technology Development2005 — 2007Cambridge, MA
- Massachusetts General HospitalAssociate Biologist2002 — 2005
- Harvard Medical SchoolHoward Hughes Postdoctoral Scientist in Molecular Biology1999 — 2002Department of Molecular Biology, Massachusetts General Hospital
Education
- University of VirginiaPhD, Chemistry1993 — 1999
- University of VirginiaBA, Chemistry1987 — 1991
Skills & more
C Level ManagementC-LevelC SuiteLeadership1Molecular Biology15Drug Development17Drug Discovery22Primary PharmacologyMolecular & Cellular Biology2Ion Channel Biology involved in Pain SignalingMolecular Immunology1IND & CTD Preparation
+12 more
Medicinal ChemistryMolecular ModelingHigh Throughput ScreeningMolecular OncologyChemical GenomicsResearch Program ManagementVirtual Program ManagementResearch ProjectsCommunicationGenomicsAssay DevelopmentBiotechnologyFrom Glenn's professional profile.
Colleagues at atai Life Sciences
Amir Kalali
Director at atai Life Sciences
Andrea Heslin Smiley
Director at atai Life Sciences
Anne Johnson
Chief Accounting Officer at atai Life Sciences
Christian Angermayer
Founder and Chairman of the Board at atai Life Sciences
Gerd Kochendoerfer
Chief Operating Officer at atai Life Sciences
John Hoffman
Director at atai Life Sciences
Kevin Craig
Chief Medical Officer at atai Life Sciences
Laurent Fischer
Director at atai Life Sciences
Frequently asked questions
- Where does Glenn Short work?
- Glenn Short is Chief Scientific Officer at atai Life Sciences.
Same school
Also attended University of Virginia400
Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesFrank RotmanCo-Founder and Partner Emeritus at QED InvestorsMegan LightcapPartner, Creator Fund at Slow Ventures
+ 394 more
Shared employers
Also worked at Axial Biotherapeutics, Inc.4
Also worked at Massachusetts General Hospital58
Ben RobbinsInvestor at GV (Google Ventures)David KaufmanInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJefte DrijversInvestor at Third Rock VenturesDan GebremedhinPartner at Flare Capital PartnersRochelle WalenskyExecutive Partner at Flare Capital Partners
+ 52 more
Also worked at Harvard Medical School162
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital
+ 156 more